More Positive Survival Data in Lung Cancer With Perioperative Therapy

(MedPage Today) -- SAN DIEGO -- Patients with operable non-small cell lung cancer (NSCLC) had significantly longer event-free survival (EFS) with perioperative chemoimmunotherapy, a large randomized trial from China showed. After a median follow...
Source
MedPage Today
Opens original article in a new tab



